Cardiawave has secured three U.S. patents for its Valvosoft ultrasound device for treatment of aortic stenosis.
The company is currently conducting a clinical study in Europe to obtain the CE Mark there for Valvosoft; ultimately, it plans to bring the device to the American market, it said.